Characterization of IGFBP2-mediated pathways in pancreatic cancer cells may provide molecular insights into the progression of pancreatic cancer and suggest potential therapeutic targets for pancreatic cancer patients with elevated IGFBP2. This evidence concerns the gene IGFBP2 and pancreatic neoplasm.